As of 2025-12-21, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is (91.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.65 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -822.4%.
The range of the Relative Valuation is (164.33) - 6.30 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.8x - 33.6x | 29.6x |
| Forward P/E multiples | 29.8x - 40.4x | 35.0x |
| Fair Price | (164.33) - 6.30 | (91.39) |
| Upside | -1399.0% - -50.2% | -822.4% |
| Date | P/E |
| 2025-12-19 | -1.99 |
| 2025-12-18 | -2.05 |
| 2025-12-17 | -2.05 |
| 2025-12-16 | -2.04 |
| 2025-12-15 | -2.12 |
| 2025-12-12 | -2.11 |
| 2025-12-11 | -2.21 |
| 2025-12-10 | -2.15 |
| 2025-12-09 | -2.07 |
| 2025-12-08 | -2.05 |
| 2025-12-05 | -2.08 |
| 2025-12-04 | -2.13 |
| 2025-12-03 | -2.12 |
| 2025-12-02 | -2.07 |
| 2025-12-01 | -2.05 |
| 2025-11-28 | -2.06 |
| 2025-11-26 | -2.06 |
| 2025-11-25 | -2.08 |
| 2025-11-24 | -1.96 |
| 2025-11-21 | -1.89 |
| 2025-11-20 | -1.74 |
| 2025-11-19 | -1.75 |
| 2025-11-18 | -1.80 |
| 2025-11-17 | -1.84 |
| 2025-11-14 | -1.85 |
| 2025-11-13 | -1.89 |
| 2025-11-12 | -1.90 |
| 2025-11-11 | -1.94 |
| 2025-11-10 | -1.92 |
| 2025-11-07 | -1.89 |
| 2025-11-06 | -1.76 |
| 2025-11-05 | -1.79 |
| 2025-11-04 | -1.78 |
| 2025-11-03 | -1.81 |
| 2025-10-31 | -1.89 |
| 2025-10-30 | -1.86 |
| 2025-10-29 | -2.43 |
| 2025-10-28 | -2.45 |
| 2025-10-27 | -2.50 |
| 2025-10-24 | -2.53 |
| 2025-10-23 | -2.50 |
| 2025-10-22 | -2.43 |
| 2025-10-21 | -2.50 |
| 2025-10-20 | -2.47 |
| 2025-10-17 | -2.37 |
| 2025-10-16 | -2.30 |
| 2025-10-15 | -2.24 |
| 2025-10-14 | -2.26 |
| 2025-10-13 | -2.14 |
| 2025-10-10 | -2.10 |